![Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00261-023-03893-2/MediaObjects/261_2023_3893_Figa_HTML.png)
Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology
![Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07186-5/MediaObjects/12885_2020_7186_Fig4_HTML.png)
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
![HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04230-8/MediaObjects/432_2022_4230_Fig1_HTML.png)
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology
![Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0344033820306968-gr4.jpg)
Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect
Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum
Diseases of the Colon & Rectum - Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol NRG Oncology/NSABP R-04 - the latest #DCRJournal #ColorectalCancer
![Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2014.128/MediaObjects/41379_2015_Article_BFmodpathol2014128_Fig1_HTML.jpg)